Apart from collaboration with China and United Arab Emirates (UAE), Indonesia is also working with South Korea to develop a candidate vaccine for COVID-19 through a cooperation between Kalbe Farma (KLBF) and Genexine Inc. The vaccine candidate developed by Kalbe-Genexine is expected to go through the second phase of clinical trial in Indonesia this month.

To subscribe please click here